Elicit vs Semantic Scholar

Elicit focuses on evidence-grade workflows: it searches 138M papers and 545K clinical trials, but its edge is the Research Agent (launched Aug 2026) that gathers evidence and creates fully cited artifacts (reports, tables, figures). The Systematic Review workflow now supports PRISMA 2020—reproducible and auditable steps. You can screen up to 1,000 papers, extract 20,000 data points, and export to RIS/CSV/BIB/PDF/DOCX, with Zotero import. Semantic Scholar offers free natural-language search across 237M papers, enriched with citation graphs, author profiles, and TLDR summaries. Its Semantic Reader beta adds augmented reading, and the public API (updated with improved docs and stability) is a developer-friendly, no-cost backbone. While Elicit requires a paid plan for advanced features, Semantic Scholar is entirely free—but only Elicit supports PRISMA-style screening and automated data extraction, which is critical for systematic reviews. If you need sentence-level citations for AI claims, Elicit's output is more rigorous; Semantic Scholar's TLDRs are great for quick understanding but lack that citation depth.

Elicit uses freemium: a free tier exists, but advanced features—like the Systematic Review workflow and Research Agent's full capacity—start at $39/mo. Recent news (June 2026) says usage now runs on a monthly usage pool for flexibility, which may benefit heavy users. Semantic Scholar is 100% free, with no paid tiers; even the API is free. If your budget is zero and you need breadth, Semantic Scholar wins. If you're conducting systematic reviews or need data extraction at scale, the $39/mo for Elicit is a direct investment in time saved—manually screening thousands of papers costs more. However, for occasional literature checks, the free tiers of both work, but Elicit's free tier is limited, pushing power users to pay. Semantic Scholar's free API is particularly valuable for developers building scholarly tools without ongoing costs.